Clinicians in Edinburgh have transplanted a 19-year-old man’s own testicular tissue, frozen before chemotherapy, back into his body. The procedure, carried out in August 2026, is the first reported testicular-tissue transplant of its kind in the UK, according to the University of Edinburgh and a Guardian report.
The transplant does not yet show that the patient has regained sperm production or fertility. Clinicians plan to monitor him and examine some of the transplanted tissue after eight months to check whether sperm have developed. The patient has also acknowledged that the outcome is not known.
Tissue stored before chemotherapy
The patient, whose name has not been disclosed at his request, had tissue collected and frozen in 2023 before he received high-dose chemotherapy as part of a bone-marrow transplant for a serious blood disorder. The sources do not identify the disorder. Tests conducted three years after treatment found no sperm in his semen, according to the university and the Guardian.
The operation used the patient’s own stored tissue, rather than tissue from a donor. It contains spermatogonial stem cells, which can develop into sperm from puberty onwards. The aim of the approach is to preserve a possibility of future fertility for patients whose treatment threatens sperm production.
That aim remains a possibility, not an outcome demonstrated in the Edinburgh patient. The tissue has been returned to his body, but there is no confirmed evidence yet that it has produced sperm or that he will be able to have biological children.
Earlier human case reported in Belgium
The UK procedure is not the first reported human testicular-tissue transplant. The University of Edinburgh describes a Belgian case as the first human demonstration of the approach. In a May 2026 report, the Guardian said a Belgian patient produced sperm from tissue frozen before childhood chemotherapy and transplanted later. That result is separate from the Edinburgh patient’s case.
The distinction matters because the Edinburgh procedure is an early clinical step, not evidence that the technique has restored fertility in this patient. Its outcome will depend on whether the transplanted tissue resumes sperm production, which clinicians have yet to determine.
A potential option for younger patients
Testicular tissue storage may be relevant to boys who are too young to provide a semen sample before cancer treatment or another treatment that could affect fertility. The procedure offers a possible future route to using tissue preserved before treatment, although this case alone cannot establish how often transplants will lead to sperm production or pregnancy.
The University of Edinburgh says more than 1,200 people in the UK and 3,100 worldwide have had testicular tissue stored for potential future use. Those figures refer to tissue storage, not successful transplants or restored fertility.